More and more imaging researchers are starting to examine the potential of using fibroblast activation protein inhibitors (FAPI) to manage patients with suspected cardiovascular disease.
The BENEFIT-HF trial, scheduled to begin enrollment in the months ahead, could significantly increase the number of patients eligible for CVRx's Barostim therapy.
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.
Gene-editing drugs have shown potential to treat a wide variety of diseases, and this will be one of the first in cardiovascular medicine to begin human trials.
Researchers tracked data from more than 200 patients who underwent PCI from August 2020 to July 2022, sharing their findings in JACC: Cardiovascular Interventions.
Hypertension caused by unilateral aldosterone-producing adrenal adenomas is curable by laparoscopic removal of the entire adrenal gland, but the invasiveness and recovery time can deter patients from the treatment.
The annual conference is now in its fourth year. Attendees are encouraged to leave their ties, jackets and skirts at home and embrace a more casual dress code.
The checklist was created to walk researchers through every operational step of using portable MRI, from creating protocols to prepping patients, ensuring patient safety, handling incidental findings, data privacy and more.
Jessica Porembka, MD, of the breast imaging division at University of Texas Southwestern Medical Center, said an ultrasound-first strategy for these lesions in DBT is cost-effective and improves efficiency.
Radiology researchers have developed and validated an automated program for tracking incidental imaging findings. The system facilitates communications between radiologists, patients and primary care providers whenever such findings turn up.
